2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   7

Issue No. :  10

Year :  2014

Pages :   1190-1192

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Registration

Allready Registrered
Click to Login

Triple Combination Antiviral Therapy



Address:   Kaur Simaranjit, Kaur Kuldeep, Kaur Herbaksh
Assistant Professor, M.M College of Nursing, Mullana Ambala, Haryana
*Corresponding Author
DOI No: Not Available

ABSTRACT:
Combination antiviral therapy helps to prevent the virus that causes hepatitis C from reproducing in the body along with HIV. Peg interferon and Ribavirin are combined to give the best response to treatment in case of HIV Positive. A protease inhibitor (such as Boceprevir or telaprevir) also may be given along with peg interferon and Ribavirin. Combination antiviral therapy is prescribed for those who have ongoing (chronic) hepatitis C infection. This therapy has certain side-effects that comes with medicine. Usually the benefits of the medicine are more important than any minor side effects i. e Fatigue, headache, muscle and joint aches etc. Periodic liver function tests and a liver biopsy every 3 to 5 years come in the special considerations. Follow-up care is a key part of treatment and safety. One has to be sure to make and go to all appointments, and call the doctor if there is any problem.
KEYWORDS:
Combination Antiviral Therapy.
Cite:
Kaur Simaranjit, Kaur Kuldeep, Kaur Herbaksh. Triple Combination Antiviral Therapy. Research J. Pharm. and Tech. 7(10): Oct. 2014 Page 1190-1192.
[View HTML]      [View PDF]



Visitor's No. :   644524